stars 1 stars 2 stars 3

VaxForm specializes in the development of vaccine formulations. Our QYNDR oral delivery platform is revolutionizing mucosal vaccination. Press Releases: 24Sep2024 - VaxForm publishes manuscript in the journal Vaccines entitled "Formulation Attributes Impact Immune Profile of an Oral and Thermostable COVID-19 Subunit Vaccine" https://www.mdpi.com/2076-393X/12/10/1087/pdf

VaxForm Questions

The VaxForm annual revenue was $202000 in 2026.

Garry Morefield is the President of VaxForm.

3 people are employed at VaxForm.

VaxForm is based in Bethlehem, Pennsylvania.

The NAICS codes for VaxForm are [32541, 32, 325414, 3254, 325].

The SIC codes for VaxForm are [283, 28].

Top VaxForm Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users